Medicina Legal, Psiquiatría y Patología
Departament
University Hospital of Lausanne
Lausana, SuizaPublicacions en col·laboració amb investigadors/es de University Hospital of Lausanne (24)
2024
-
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272
-
PsyCog: A computerised mini battery for assessing cognition in psychosis
Schizophrenia Research: Cognition, Vol. 37
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study
Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106
-
Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis
British Journal of Psychiatry, Vol. 31, Núm. 2
-
Perceived impact of the COVID-19 pandemic on child and adolescent psychiatric services after 1 year (February/March 2021): ESCAP CovCAP survey
European Child and Adolescent Psychiatry, Vol. 32, Núm. 2, pp. 249-256
-
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe
ESMO Open, Vol. 8, Núm. 5
-
Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: The EU-GEI study
Psychological Medicine, Vol. 53, Núm. 5, pp. 1970-1978
-
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study
Psychological medicine, Vol. 53, Núm. 15, pp. 7418-7427
-
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study
Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580
-
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; The EU-GEI study
Psychological Medicine, Vol. 53, Núm. 8, pp. 3396-3405
2022
-
Clinical high risk for psychosis paradigm for CAP: do not throw the baby out with the bathwater
European Child and Adolescent Psychiatry
-
Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure
Human Brain Mapping, Vol. 43, Núm. 1, pp. 37-55
-
Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs
Human Brain Mapping, Vol. 43, Núm. 1, pp. 300-328
2021
-
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders
JAMA Psychiatry, Vol. 78, Núm. 1, pp. 47-63
2020
-
Clinical high risk for psychosis model in children and adolescents: a joint position statement of ESCAP Clinical Division and Research Academy
European Child and Adolescent Psychiatry
-
Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA
NeuroImage, Vol. 218
-
Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention
JAMA Psychiatry, Vol. 77, Núm. 7, pp. 755-765
-
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
Journal of Thoracic Oncology, Vol. 15, Núm. 9, pp. 1409-1424
2019
-
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)
European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1301-1311